Try our Advanced Search for more refined results
Life Sciences - August, 2023
319 articles
- Fed. Circ. Puts More Patents At Risk Of Double-Patenting Ax
- Plan To Reschedule Pot Buoys Industry But Angers Reformers
- Rite Aid Atty's 'Money Grab' Comments Don't Justify New Trial
- Trans Teens Say 11th Circ. Ruling Doesn't Affect Georgia Case
- The Basics Of Being A Knowledge Management Attorney
- 10th Circ. Won't Reconsider Nixing Military COVID Vax Suit
- Ousted Sales Rep Accuses Zimmer Of Age, Gender Bias
- The Fed. Circ. In August: New Claim Constructions In IPR
- Judge Won't Step Into Attys' Flint Settlement Fee Spat
- Challenging Standing In Antitrust Classes: The Uninjured
- $3M Judgment For Conn. Co. Will Be Defrayed By Credits
- Purdue Ch. 11 Case Exemplifies Need For 3rd-Party Releases
- Gilead Urges Calif. Appeals Court To Toss HIV Drug Claims
- Calif. Urges 9th Circ. To Mirror 1st Circ. Insulin Suit Ruling
- Medtronic Unit's Insulin Device Exposes User Data, Suit Says
- Suboxone Buyers Can't Narrow Product Market Ahead Of Trial
- Mallinckrodt Cleared To Tap Into $250M Of Ch. 11 Financing
- IVIG Patients Can't Get Class Cert. In AmerisourceBergen Suit
- Pharma Cos. Caused Zantac-Linked Cancers, Conn. Suit Says
- HHS Sends New Pot Scheduling Recommendation To DEA
- What Big Tobacco's Cannabis Investments Mean For Market
- Michigan Gov. Eyes Paid Leave, Clean Energy For Fall Agenda
- These Firms Have The Most Women In Equity Partnerships
- Novo Nordisk Snags Obesity-Focused Biz For Up To $515M
- HHS Fans Legal Flames With Medicare Drug Negotiation Picks
- 11th Circ. Upholds $40M Sanctions Against Ga. Pharma Co.
- US Chamber Backs Amgen In FTC's $27.8B Merger Challenge
- Canadian Cos. Say Scammer Stole $1M For Fake Refinery Deal
- DC Circ. Says FDA Botched Part Of E-Cig Review
- CVS, Others Say Consumers Can't 'Free Ride' HIV Drugs Deal
- Fla. Medical Supplier Lincare Pays $29M In Medicare FCA Suit
- Dems Want FDA To Work With USPTO On Drug Pricing
- Biopharma Co. Catalent Cuts Deal With Activist Elliott
- Gilead, Generics Co. Beat HIV Drug Antitrust Suit For Now
- To Hire And Keep Top Talent, Think Beyond Compensation
- Ex-Mylan CIO Waives Atty Conflict For Insider Trading Case
- A Deep Dive Into Law360 Pulse's Women In Law Report
- How Merger Review Overhaul Could Affect Health Industry
- Fla. Judge Says Geneticist Wasn't OK'd To Sell Cloned Horses
- Amid Legal Blitz, HHS Reveals 1st Drugs For Negotiations
- Supplement Co. Owner Nets Nearly $550K Win In TM Suit
- 2nd Circ. Revives Investor Suit Against Synergy Pharma Exec
- Pfizer Takes Aim At Moderna COVID Vaccine Patents At PTAB
- FTC Pulls Amgen-Horizon Merger Case, Citing Possible Deal
- Catching Up With Delaware's Chancery Court
- Drug Co. Says Exclusion Doesn't Bar Subpoena Coverage
- What Circuit Split May Mean For FCA Kickback Liability
- Ex-Partners Say They Were Shut Out Of Flint Settlement Fees
- Dickson Minto-Led Centene Selling Circle Health For $1.2B
- Danaher To Buy Life Sciences Co. Abcam In $5.7B Deal
- Mallinckrodt Files Second Ch. 11 To Wipe Out $1.9B Of Debt
- Alnylam, Moderna Agree To COVID Vax Patent Judgment
- AppHarvest Gets $30M In DIP Financing To Get To Ch. 11 Sale
- DC Circ. Won't Revive FTC's Endo-Impax Deal Suit
- Abbott Labs Sued Over Sucralose In Glucerna Health Shakes
- 3rd Circ. Rejects FCA Defense Using 'Single Escobar Factor'
- Sorrento Approved For $105M Scilex Stock Sale In Ch. 11
- AARP Fights Block Of Medicare Drug Price Negotiations
- A Closer Look At China's Landmark Pharma Antitrust Ruling
- AstraZeneca Joins Big Pharma's Offensive On Price Talks
- NJ Judge OKs Blanket Confidentiality In COVID Firing Suit
- Mich. Judge Approves $9.5M Data-Sharing Settlement
- 9th Circ. Says Non-MDL Clients Can Be Part Of Common Fund
- More States Should Join Effort To Close Legal Services Gap
- Taxation With Representation: Kirkland, Skadden
- UK Litigation Roundup: Here's What You Missed In London
- Supplement Co. Gets Versalyte Flavor Suit Trimmed
- W.Va. AG Knocks Out Bulk Of Challenge To Abortion Pill Ban
- Geron Investors' Attys Get $4.3M From $24M Stock-Drop Deal
- Chancery Kills Adamis Investor's Suit From Failed Proxy Fight
- Ex-Lincare CEO Fights Injunction In Trade Secrets Suit
- EPA Pledges Final Ethylene Oxide Rule In Deal With Activists
- Biogen Strikes $9.75M Deal In ERISA 401(k) Investment Suit
- Justices Told Big Pharma Can't Escape Terror-Funding Claims
- McCarter & English Asks For End To Legal Malpractice Suit
- Identifying Trends And Tips In Litigation Financing Disclosure
- Bradley Arant Atty Accused Of Improper Mid-Deposition Texts
- Mich. Can Keep Infant Data While It Appeals Destruction Order
- Bid Protest Spotlight: Personnel Loss, Conflicts, Timeliness
- Justices Urged To Nix Abortion Foes' Bid In Covert-Video Case
- Masimo Hit With Investor Suit Over Revenue Disclosures
- Teva Escapes Ex-Exec's Age Discrimination Case
- 9th Circ. To Review Class Certification In Diabetes Drug Suit
- SC High Court Backs 6-Week Abortion Ban
- High Court Ruling Doesn't Save Christian Clinic's Tossed Suit
- Canadian Tribe's Lawsuit 'Perplexing,' Purdue Tells NY Court
- 2023 Farm Bill Could Follow Md., Minn. Or NY's Lead On Hemp
- DHS Aims To Punt $8.5M Immigration Fee Suit To Claims Court
- A Defendant-Friendly Patent Trend In Central District Of Calif.
- FDA Regulatory Partner Joins King & Spalding In DC
- Boston Biotech Biz Raises $150M In Series B Funding Round
- Mallinckrodt Strikes Creditor Deal For Second Ch. 11 Case
- Walmart's Opioid Deal Advances With States' Participation
- Biotech Firm Can't Nix Researcher's Suit Tied To $35M Buyout
- Va. Judge Won't Order FDA To Maintain Abortion Drug Access
- Amgen, Horizon Say FTC Merger Challenge 'Defies Logic'
- SEC Fines 5 Issuers Over Flawed Late-Filing Disclosures
- Lundbeck Sues USPTO To Extend Patent Term For PTSD Drug
- Fed. Circ. Backs PTAB Invalidation Of Hair Loss Patent
- Judge Clears Court-Appointed Attys Of Wrongful Death Claims
- Decrease In Multiple Petitions Follows USPTO Guidance
- UMich, Striking Grad Union Reach Tentative Agreement
- Tilray Gets Securities Suit Tossed On Reconsideration
- Paraquat, Parkinson's Share Links, Bellwether Judge Hears
- Insurer Can't Escape Covering Sleep Machine Class Actions
- Ga. To Appeal Block On New Hormone Treatment Law
- Best Practices For Atty-Client Privilege In Patent Litigation
- The Pop Culture Docket: Judge Elrod On 'Jury Duty'
- Teva, Glenmark To Pay $305M In Latest DOJ Generics Deal
- DuPont Sells Ownership Interest In Delrin Biz For $1.8B
- Catching Up With Delaware's Chancery Court
- Boehringer Challenges Medicare Drug Price Negotiation Law
- Ga. Justices Say Hospital Can't Fight Bill Nixing Its Opioid Suit
- Vitamin Co.'s Arbitral Win Too Small To Beat Rival's $1.1M Fee
- Teva Wants In On FDA Suit To Defend Dibs On Xifaxan Generic
- Alkermes Gets $194M Award Against Janssen Approved
- Tech Giants, Edwards Lifesciences Fight Fintiv In Calif. Court
- Surgery Monitoring Deal May Violate Kickback Law, HHS Says
- Ex-Lab Co. CEO Gets 27 Years For $187M Medicare Fraud
- ITC Tells ALJ To Rethink Biomolecular Patent Claims
- SPACs Seek Overseas Targets As Domestic Options Shrink
- 4 Firms Guide SPAC Deal For $300M Pregnancy Care Co. Nuvo
- SEC Says Ga. Biz Owner Conned Investors In Crypto Scheme
- 4 Business-Building Strategies For Introvert Attorneys
- Fee Request For Malpractice Suit 'Stunning,' Pharma Biz Says
- Splenda Maker Falsely Touts Diabetes Benefits, Suit Says
- Cleveland Clinic Promotes Akron Unit GC To Compliance Chief
- Foley Hoag Adds Cooley IP Atty In Boston
- Taxation With Representation: Davis Polk, V&E
- Oclaro, Investors Persuade Skeptical Judge To OK $15M Deal
- IP Forecast: Pinterest Looks To Defend DMCA Win At 9th Circ.
- Leadership Redo Sought In Camp Lejeune Suits
- 2 Lose By Default In Suit Alleging Hijack Of Biosciences Co.
- US Sets Up Panel Targeting Mexico's GMO Corn Measures
- DOJ Wants Equal Access To Docs in Ex-Exec's Criminal Case
- PTAB To Eye Cancer Treatment IP Over EU Branch Objections
- Whistleblowing Eye Doc Asks Justices To Save Kickback Law
- Judge Says Ex-Insys CEO Has To Repay $6M In Defense Fees
- Illumina Tells 5th Circ. FTC Merger Block Unconstitutional
- Sales Reps In The Operating Room: How To Manage The Risks
- Maine Hospital Workers Want Justices To Review Vax Mandate
- Dog Food Cos. Say 8th Circ. Should Rethink Remand Order
- Lewis Brisbois Says Device Maker Owes $1M In Legal Fees
- 3 Ways Justices' Disclosure Defenses Miss The Ethical Point
- Maternity Co. Twisted Facts In Trade Secrets Row, Court Told
- Morgan Lewis, Freshfields Build $108M Cell Biology Co. Deal
- Otsuka Wins Block On Cancer Drug Lonsurf's Generic Version
- Brita Overhypes Devices' Water Filtering Abilities, Suit Says
- Implant Co. Says Whistleblower FCA Suits Unconstitutional
- Forte Investor Accuses Directors Of Stifling Stockholder Votes
- Delaware Federal Judge Upholds UCB's Epilepsy Drug Patent
- Red Cross Says DOJ Wrong On Antitrust Immunity
- Monsanto Wins Roundup Venue Fight At Mo. High Court
- Insys Trust Wants Insurer To Pay Share Of Ch. 11 Settlement
- Humana, Aetna Can't Return Seroquel Suit To Calif. Court
- Fla. Pharmacy Says Obesity Drug Suit Is Preempted By FDCA
- Fed. Circ. Won't Revive Cancer IP, To Newman's Dismay
- Home Health Co. Owner Admits To Hiding $2M From IRS
- IPR Pointers In Recent PTAB Discretionary Denials
- 5th Circ. Upholds Abortion Pill's Approval, But Backs Limits
- Aurora Health Strikes $12.25M Deal To End Pixel Privacy Suit
- Don't Ban The Apple Watch, Groups Urge Fed. Circ.
- Foam Co. Slams Insurers' Bid To Toss PFAS Coverage Suit
- UPenn Docs Seek To Dodge $183M Birth Injury Verdict
- 4th Circ. Resurrects FCA Suit Over Walgreens Medicaid Fraud
- DePuy Counsel Says Spinal IP Suit Is Worthy Of Atty Fees
- Life Sentence Advised For Ex-CEO In $187M Medicare Fraud
- Pa. Lab Owner Gets Prison For Medicare Kickback Scheme
- Limitations In Seeking Trade Dress With Patent Protection
- 7th Circ. Refuses To Revisit $10M Drug Co. Coverage Ruling
- Utah Man Arrested 3 Years After COVID Cure Charges
- Catalent Brass Face Investor Suit Over COVID Vaccine Woes
- Becton Dickinson Escapes Ex-Worker's Obesity Bias Suit
- Proskauer Faces Trial For Alleged $636M Error As Talks Fail
- Teva Scores FCA Trial Delay, Kickback Law Appeal At 1st Circ.
- Drug Negotiation Suits Reflect Lobbying Failures, HHS Says
- 3rd-Party Releases In Ch. 11 May Die At Supreme Court
- Investors Sue Viatris Brass For Selling Off Biosimilars
- HIV Drug Buyers Want New Antitrust Trial
- Implications Of PTAB's Decision On Scope Of Work Product
- Life Sciences Biz Paying Up To $200M For CBD Drugmaker
- Orrick Slapped With Data Breach Suit
- Genentech Denied Quick Exit In 'Uncertain' 401(k) Fees Suit
- Cellino Fights Atty's Bid To Block Fees In J&J Mesh MDL
- Ill. Judge Unfreezes Ex-Outcome Health CEO's $5M
- Ohio Justices Sink Challenge To Abortion Rights Referendum
- Walmart Can't Fry Fish Oil Supplement False Ad Lawsuit
- NJ Judge Won't Impose 6 Month Ch. 11 Bar On J&J Talc Unit
- 7th Circ. Won't Undo CR Bard's $3.3M Vein Filter Verdict Loss
- Fed. Circ. Backs PTAB's Trim Of Urine Test Patent
- Biden Admin Targets Purdue, 'Ghost Guns' In Shadow Dockets
- Animal Health Co. Merck Can't Sink Pet Microchip Lawsuit
- Amgen, Horizon Say FTC Constitutionality Key To Merger Row
- Kaiser Doctors Didn't Flag Cancerous Mass, Wash. Man Says
- 8th Circ. Affirms Coloplast's Win In Mesh Injury Suit
- High Court Told Fintiv Rule Leads To 'Arbitrary Outcomes'
- DOJ Probes UnitedHealth Unit's $3.3B Amedisys Deal
- Splenda Pans Scientist's Cancer Claims As 'Fearmongering'
- 2 Firms Guide HDL Therapeutics' $480M SPAC Merger
- SEC Investigating Illumina-Grail Deal And Management Teams
- Amyris Ok'd To Tap Part Of $190M DIP Loan For Quick Ch. 11
- Comparing US And EU Approaches To Health AI Regulation
- Caregiver Flexibility Is Crucial For Atty Engagement, Retention
- Standing Issues Prevail In Wake Of Calif. Competition Ruling
- UK Litigation Roundup: Here's What You Missed In London
- Henrietta Lacks' Family Sues Ultragenyx Over Stolen Cells
- Fed. Circ. Wary Of Masimo Bid To Revive IP In Apple Feud
- WilmerHale Wants To Skip Ch. 11 Client Disclosures
- Cancer Drug's Delay Amounts To Extortion, Clinic Says
- Ex-Dental Co. Worker's Pregnancy Bias Claims Head To Trial
- Faruqi & Faruqi Will Lead Investors In COVID Drug Claims Suit
- Gilead Sciences Inks $247M Deal For HIV Antitrust Claims
- Justices Halt Purdue Ch. 11 Plan Over Sackler Releases
- Blue Cross Can Subpoena Lab Exec's Atty In Fraud Suit
- 1st Circ. Affirms $1.7M Award To NuVasive In Noncompete Suit
- MoCRA Will Give Cosmetics Litigation A Makeover
- Duke Paid Female Scientist Less Than Male Peers, Suit Says
- High Court Ruling No Help To Ex-Aegerion Rep, Feds Say
- Bio Venture Amyris Files Ch. 11 With $1.1B In Debt
- Juul's $255M MDL Gets Nod, Judge Mulls $76.5M Atty Fee Bid
- AstraZeneca Unit Dodges PTAB Review For $2B Cancer Drug
- Justices Urged To Skip Eligibility Case For Blood Test Patents
- Del. Justices Say Pharma Co. Buyout Of Drugmaker Was Fair
- PTAB Reform Bill Won't Help Cut Drug Prices, Groups Say
- Ex-VP Says Medical Biz Fired Her For Raising Diversity Issues
- Pharmacy Group Wants Last PharmacyChecker Claim Nixed
- What Justices' Pork Ruling Means For Interstate Cannabis
- Pfizer Says 401(k) Mismanagement Claims Must Be Tossed
- Surgery Patient Says His Arthrex Shoulder Device Broke
- Greenberg Traurig Adds 2 Reed Smith Health Care Pros
- Fed. Circ. Told Apple Watch Ban Could Turn ITC 'Meaningless'
- Ohioans Reject Proposal Viewed As Abortion Rights Hurdle
- Individual Inventors Face Rough Day At Federal Circuit
- NC Republicans Fight Shutdown Bid To Abortion Law Sections
- Takeda Agrees To Pay Texas $42M Over ADHD Drug Marketing
- In-Office Engagement Is Essential To Associate Development
- Holland & Knight Brings On Reed Smith Product Liability Duo
- Complex Hemp Processes Need Nimble Regulatory Approach
- PTAB Invalidates Some Claims In Stryker Bone Plate Patent
- South Carolina Joins Wave Of PFAS Suits Against 3M, DuPont
- Judge Backs Acorda's $16.6M Award In MS Drug Row
- Doc Seeks $46M In Damages After Penile Implant Trial Win
- Sorrento OK'd For New $100M Ch. 11 DIP Loan In Texas
- J&J Metal Hip Implant Suits Consolidated In Wash. State Court
- NC Psychologist Settles FCA Suit Over Brain-Testing Device
- Nektar Says Eli Lilly Botched Autoimmune Drug Trials
- 3 Firms Steer $570M Merger Of Pharmacy Management Cos.
- Biotech Firm Says It Was Stiffed Over COVID-19 Tests
- Mayo Clinic Beats Christian Workers' Bias Suits Over Vaccine
- Natera, CareDx Both Blocked From Making False Ad Claims
- Fed. Circ. Tells PTAB To Rethink Medtronic Patent Ruling
- 2nd Circ. Lets Conn. Vaccine Mandate Suit Survive On 1 Claim
- A Judge's Pitch To Revive The Jury Trial
- What Patent Bills Would Mean For Infringement Litigation
- Texas Judge Blocks Abortion Bans In Medical Emergencies
- US Chamber Says Big Pharma Can't Be Blamed For Terrorism
- Kentucky Trans Youth Urge Quick Ruling On Gender Care Ban
- PTAB Has To Eye Hormone Drug Fight Again, Vidal Finds
- Purdue Pharma Asks Justices To Reject Ch. 11 Challenge
- IRS, Treasury To Float Regs On Scope Of Drug Negotiation Tax
- Amazon And Pharma Cos. Sued Over Tainted Eye Drops
- FTC Defends Illumina-Grail Block — And Its Constitutionality
- Insurer Says No Coverage For $5.4M Texas Contamination Suit
- Ex-Hospital Employee Defends COVID Vax Bias Suit
- DOJ Says Red Cross Not Immune From Platelet Antitrust Suit
- Pharma Cos. Can't Trim Gout Drug Antitrust Claims
- JPML Centralizes Insulin Price-Fixing Suits In New Jersey
- NC Lab Will Pay $1.9M To Settle FCA Kickback Case
- J&J Can't Appeal Dismissal Bids In Tylenol Birth Defect MDL
- Fla. Hospital Patients Say They Were Targeted In Data Breach
- Ohio Judge Trims Tech Co.'s $3M E-Commerce IP Theft Suit
- Negotiating AI-Life Sciences Partnerships To Minimize IP Risk
- How To Recognize And Recover From Lawyer Loneliness
- Feds Granted Protected Mass. Patient Data In Lead Test Case
- UK Litigation Roundup: Here's What You Missed In London
- Becton Investors Get Cert. In Securities Suit Over Pump Recall
- NJ Panel Backs DEP Standards For 'Forever Chemicals'
- Becton's Pyxis Safe Targeted With Ill. Biometric Claims
- 9th Circ. Revives Atty's FCA Suit Against Valeant Over Apriso
- Teva Signs $126M Opioid Deal With Hospitals
- Euro Industry Groups Voice Opposition To PFAS Ban
- Del. Court Sends Patent Suit Against PacBio To Calif.
- Sotera Blasts Shareholder Suit Over $363M Emissions Verdict
- Supplement Co., Manager Fined $1M For COVID Cure Claims
- Litigation Funding Disclosure Should Be Mandatory
- 4 Employer Action Steps For New Mental Health Parity Rules
- Recalling USWNT's Legal PR Playbook Amid World Cup Bid
- Judge Tosses Firm's Bid To Boot Future J&J Talc Claims Rep
- FDA Snags Early Win In Vanda Gastro Drug Review Challenge
- Former Pharma CFO's Ex-Girlfriend Fined For Insider Trading
- Medtronic Can't Yet Ditch Rival's Surgical Market Antitrust Suit
- Advocacy Groups, Scholars Back FTC Against Illumina Appeal
- 9th Circ. Nixes Injunction On Guam Abortion-Consultation Law
- Blank Spot On Form Dooms $637K VA Equipment Lease Claim
- Eli Lilly And Novo Nordisk Sued Over Risks Of Diabetes Drugs
- J&J Unit's Talc Claimants Seek Temporary Bar On 3rd Ch. 11
- Shuttered Philly Pharmacies To Pay $3.5M To End FCA Claims
- Hedge Fund Priest Tells High Court SEC Case Chills Speech
- Latham-Led SK Capital Secures $800M For 2nd Catalyst Fund
- What Companies Must Know About Product Recalls
- The Hottest Health And Life Sciences Policy In 2023's 2nd Half
- Genentech Sues Sandoz Over Generic Lung Disease Drug
- AstraZeneca Sets Aside $510M For Bristol-Myers Patent Deal
- Families Seek Cert In Fla. Trans Health Care Suit
- Ill. Judge Urges Deal Over Ex-Outcome CEO's Frozen $5M
- PG&E Sued Over Smoke Health Harms Of Dixie, Fly Wildfires
- Biden Wants To Spend More Money On US Inventions
- Sorrento Hits Snag On $200M Scilex Stock Sale In Ch. 11
- Forced-Labor Probes Call Out 2 Chinese Companies
- Proskauer, Investor To Try Mediation Over Alleged $636M Error
- Judge Backs Moderna On Key Patent Terms In Pfizer Vax Row
- State Farm Saves Billions With Minority Fraud Plot, Co. Says
- It's Not You, It's Me: Breaking Up With Mass. FCA Prosecutors
- Fresenius Can't Kill Nausea Drug IP Claims As Indefinite
- Likely Outcomes In PTAB Director Reviews After End Of POP
- FTC Hails Nix Of $875M Reproductive Health Tech Deal
- Fla. Co. Fined $7.6M Over False Smoking Cessation Claims
- Thermo Fisher Settles Suit Over Use Of Henrietta Lacks' Cells
- Oncology Co. Boosts Balance Sheet By $1B With EQRx Buy